12:00 AM
Jan 30, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MA09-hRPE cells: Phase I/II started

Advanced Cell began an open-label, dose-escalation, U.K. Phase I/II trial to evaluate sub-retinal transplantation of 50,000, 100,000, 150,000 and 200,000 MA09-hRPE cells...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >